← Back to Clinical Trials
Recruiting NCT06643273

NCT06643273 Evaluation of a Haptic Glove for Assessing Tactile Perception in Post-Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06643273
Status Recruiting
Phase
Sponsor Fondazione Don Carlo Gnocchi ETS
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 126 participants
Start Date 2024-10-04
Primary Completion 2027-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Robotic rehabilitationConventional rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 126 participants in total. It began in 2024-10-04 with a primary completion date of 2027-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the SCORES Haptic Glove Study is to assess the technical features, safety, and reliability of a sensor-equipped glove designed to evaluate tactile perception. This will help guide further technical and functional improvements to finalize the device. The secondary goal is to validate a new tactile sensitivity index based on data collected using the glove. This will be done in a randomized controlled multicenter study (ClinicalTrials.gov ID NCT06109324) aimed to compare the effectiveness of robotic upper limb rehabilitation to conventional treatment in improving cognitive and sensory deficits, as well as evaluating the impact of these deficits on motor recovery.

Eligibility Criteria

Inclusion Criteria: * a single event, verified by MRI or CT; * age between 18 and 85 years; * time since stroke within six months; * a demographically adjusted total score of the Montreal Cognitive Assessment (MoCA) between 15.5 and 22.23 Exclusion Criteria: * behavioural and cognitive disorders and/or reduced compliance that would interfere with active therapy; * fixed contraction deformity in the affected limb that would interfere with active therapy (ankylosis, Modified Ashworth Scale = 4); * severe deficits in visual acuity.

Contact & Investigator

Central Contact

Marco Germanotta, PhD

✉ mgermanotta@dongnocchi.it

📞 3805464652

Frequently Asked Questions

Who can join the NCT06643273 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06643273 currently recruiting?

Yes, NCT06643273 is actively recruiting participants. Contact the research team at mgermanotta@dongnocchi.it for enrollment information.

Where is the NCT06643273 trial being conducted?

This trial is being conducted at Florence, Italy, Messina, Italy, Roma, Italy.

Who is sponsoring the NCT06643273 clinical trial?

NCT06643273 is sponsored by Fondazione Don Carlo Gnocchi ETS. The trial plans to enroll 126 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology